Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Implications of the SARS-CoV-2 pandemic for the development and update of clinical practice guidelines: A viewpoint
Theresa Steeb;
Markus Follmann;
Ralf Matthias Hagen;
Carola Berking;
Markus Vincent Heppt
ABSTRACT
Following the rapid spread of a new type of coronavirus (SARS-CoV-2), nearly all countries have introduced temporary restrictions affecting daily life with “social distancing” as key intervention for slowing the spread of the virus. Despite the pandemic, the development or actualisation of medical guidelines especially in the rapidly changing field of oncology needs to be continued in order to provide up-to-date evidence- and consensus-based recommendations for shared decision-making and maintaining the treatment quality for patients. In this viewpoint, we describe potential strengths and limitations of online conferences for medical guideline development. This viewpoint will assist guideline developer in evaluating whether online conferences are an appropriate tool for their guideline conference and audience.
Citation
Please cite as:
Steeb T, Follmann M, Hagen RM, Berking C, Heppt MV
Implications of the COVID-19 Pandemic for the Development and Update of Clinical Practice Guidelines: Viewpoint